Lymphatic Malformation
Oncology·MeSH: Lymphatic Abnormalities
Prevalence
30.0 / 100K
4 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| qrx009 | Quoin Pharmaceuticals, Ltd. (QNRX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Lymphatic Malformation?
BioSniper tracks 4 drugs in development for Lymphatic Malformation across 3 companies.
How many clinical trials target Lymphatic Malformation?
There are 3 clinical trials targeting Lymphatic Malformation tracked by BioSniper.
What is the prevalence of Lymphatic Malformation?
The estimated prevalence of Lymphatic Malformation is approximately 30.0 per 100,000 population.
Deep-dive into Lymphatic Malformation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis